High Hopes and Expectations for Merck’s First Investor Day in Years
Merck is set to host its Investor Day on June 20. Investors will have a high bar of expectations because so much of Merck's story is known.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 98
Why ArQule’s Early-Stage Hematology Study Could Be Transformational
ArQule shares jumped early on Friday after the firm announced preliminary results from an early-stage study in patients with relapsed or refractory hematologic malignancies at the 2019 European Hematology Association annual meeting.
Investors Need Some Breathing Room From Savara’s Lung Treatment
Savara shares were absolutely crushed on Thursday after the company released its late-stage results for its treatment of autoimmune pulmonary alveolar proteinosis. Unfortunately, the study did not meet its primary endpoint.
Multimillion-Dollar Medical Claims Continue to Skyrocket
Whether you were in favor of or against the Affordable Care Act, it is likely of little surprise that the cost of health care has continued to rise. What also has risen handily is…
Big Biotechs Have Short Sellers on the Run
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest in most of these…
Big Pharma Sees a Rising Tide in Short Interest
The May 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
New Sickle Cell Disease Treatment Could Be a Blockbuster With $1 Billion in Sales
One relatively small clinical-stage biopharmaceutical player called Global Blood Therapeutics may be about to change how sickle cell disease treatment goes.
Meet the Newest Treatment for Autism Using Cannabidiol
Zynerba Pharma has just announced that the U.S. Patent and Trademark Office has issued a patent for the firm’s treatment of autism spectrum disorder with cannabidiol.
Is CymaBay Therapeutics’ Liver Disease Trial Sunk?
CymaBay Therapeutics shares were nearly halved early Tuesday after the company provided an update from its midstage study of seladelpar for the treatment of nonalcoholic steatohepatitis.
Why NovaBay Pharma Shares Absolutely Exploded
NovaBay shares absolutely exploded on Monday after the company announced that its eye care treatment would be readily available on Amazon.
Researchers Discover a Breakthrough Drug That May Significantly Delay Type 1 Diabetes
A monoclonal antibody called teplizumab has been shown to delay the onset of type 1 diabetes for as long as two years. About 1.25 million Americans suffer from the disease, a form of diabetes…
How ReWalk Is Capitalizing on Its Big Win
ReWalkshares took a step back on Monday after the firm announced that it would be pricing a registered direct offering for $5 million. This comes after the stock had a phenomenal week when the…
What Insys Therapeutics Gets by Filing for Chapter 11
Fentanyl-maker Insys Therapeutics has filed for bankruptcy protection while the company sells all its assets.
5 ASCO Winners That Could Still More Than Double
24/7 Wall St. has taken a look at Wedbush’s recent ASCO roundup, and we’ve picked out a few of the companies with the biggest upside potential going forward.
Fake Health News Has Become So Common New Guidelines Now Help Recognize Them
The problem of fake news has spread to health news, which can be critical to the well being of millions of American as they decide what drugs to take, what procedures to have, what…